IRIS Accounts Production v24.2.0.383 SC275804 Board of Directors Board of Directors 1.12.22 30.11.23 30.11.23 false true false false true false 11249 11846 51724 13761 52156 13164 11681 11249 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC2758042022-11-30SC2758042023-11-30SC2758042022-12-012023-11-30SC2758042021-11-30SC2758042021-12-012022-11-30SC2758042022-11-30SC275804ns15:Scotland2022-12-012023-11-30SC275804ns14:PoundSterling2022-12-012023-11-30SC275804ns10:Director12022-12-012023-11-30SC275804ns10:Director22022-12-012023-11-30SC275804ns10:PrivateLimitedCompanyLtd2022-12-012023-11-30SC275804ns10:SmallEntities2022-12-012023-11-30SC275804ns10:AuditExempt-NoAccountantsReport2022-12-012023-11-30SC275804ns10:SmallCompaniesRegimeForDirectorsReport2022-12-012023-11-30SC275804ns10:SmallCompaniesRegimeForAccounts2022-12-012023-11-30SC275804ns10:AbridgedAccounts2022-12-012023-11-30SC27580442ns10:Director22022-11-30SC27580442ns10:Director22021-11-30SC27580442ns10:Director22022-12-012023-11-30SC27580442ns10:Director22021-12-012022-11-30SC27580442ns10:Director22023-11-30SC27580442ns10:Director22022-11-30SC275804ns10:CompanySecretary12022-12-012023-11-30SC275804ns10:RegisteredOffice2022-12-012023-11-30SC275804ns5:CurrentFinancialInstruments2023-11-30SC275804ns5:CurrentFinancialInstruments2022-11-30SC275804ns5:ShareCapital2023-11-30SC275804ns5:ShareCapital2022-11-30SC275804ns5:RetainedEarningsAccumulatedLosses2023-11-30SC275804ns5:RetainedEarningsAccumulatedLosses2022-11-30SC275804ns5:PlantMachinery2022-12-012023-11-30SC275804ns5:MotorVehicles2022-12-012023-11-30SC275804ns5:ComputerEquipment2022-12-012023-11-30SC2758041ns10:Director12022-11-30SC2758041ns10:Director12021-11-30SC2758041ns10:Director12022-12-012023-11-30SC2758041ns10:Director12021-12-012022-11-30SC2758041ns10:Director12023-11-30SC2758041ns10:Director12022-11-30
REGISTERED NUMBER: SC275804 (Scotland)















Financial Statements for the Year Ended 30 November 2023

for

Balnabeen Medical Ltd.

Balnabeen Medical Ltd. (Registered number: SC275804)






Contents of the Financial Statements
for the Year Ended 30 November 2023




Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 4


Balnabeen Medical Ltd.

Company Information
for the Year Ended 30 November 2023







DIRECTORS: K S Baird
Mrs J D Baird





SECRETARY: Mrs J D Baird





REGISTERED OFFICE: Balnabeen Lodge
Conon Bridge
Dingwall
IV7 8AU





REGISTERED NUMBER: SC275804 (Scotland)





ACCOUNTANTS: Highland Accountancy Practice
Chartered Accountants
Suite 1A, Willow House
Stoneyfield Business Park
Inverness
Highland
IV2 7PA

Balnabeen Medical Ltd. (Registered number: SC275804)

Abridged Balance Sheet
30 November 2023

30.11.23 30.11.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 80,312 34,867

CURRENT ASSETS
Debtors - 23,569
Cash at bank 104,191 67,025
104,191 90,594
CREDITORS
Amounts falling due within one year 20,342 33,599
NET CURRENT ASSETS 83,849 56,995
TOTAL ASSETS LESS CURRENT
LIABILITIES

164,161

91,862

PROVISIONS FOR LIABILITIES 15,259 6,625
NET ASSETS 148,902 85,237

CAPITAL AND RESERVES
Called up share capital 4 4
Retained earnings 148,898 85,233
SHAREHOLDERS' FUNDS 148,902 85,237

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Balnabeen Medical Ltd. (Registered number: SC275804)

Abridged Balance Sheet - continued
30 November 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Balance Sheet for the year ended 30 November 2023 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 18 August 2024 and were signed on its behalf by:




K S Baird - Director



Mrs J D Baird - Director


Balnabeen Medical Ltd. (Registered number: SC275804)

Notes to the Financial Statements
for the Year Ended 30 November 2023

1. STATUTORY INFORMATION

Balnabeen Medical Ltd. is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Equipment - 25% on reducing balance
Motor Vehicles - 25% on reducing balance
Computer Equipment - 33% on cost

Tangible fixed assets are initially measured at cost and subsequently measured at cost, net of depreciation, impairment losses, and reversals of impairment losses (where applicable).

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 2 ) .

Balnabeen Medical Ltd. (Registered number: SC275804)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2023

4. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 December 2022 49,831
Additions 105,800
Disposals (42,843 )
At 30 November 2023 112,788
DEPRECIATION
At 1 December 2022 14,964
Charge for year 27,837
Eliminated on disposal (10,325 )
At 30 November 2023 32,476
NET BOOK VALUE
At 30 November 2023 80,312
At 30 November 2022 34,867

5. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 30 November 2023 and 30 November 2022:

30.11.23 30.11.22
£    £   
K S Baird and Mrs J D Baird
Balance outstanding at start of year (11,249 ) (11,846 )
Amounts advanced 51,724 13,761
Amounts repaid (52,156 ) (13,164 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (11,681 ) (11,249 )